Resources available to support the detection, intervention and management of Hypertension and Blood Pressure.
Accessing CDRC resources on SystmOne
To access the below resources you will need to be a member of the DCS group on SystmOne. To do this, please follow the instructions on the CDRC SystmOne Access webpage.
Reports
CDRC’s Quality Improvement Reports aid to identify patients with possible or un-coded Hypertension and will also help target patients for intervention.
CDRC’s Performance Reports allow you to assess the blood pressure performance of your unit.
Quality Improvement Reports
The following reports are located in the folder CDRC Quality > Cardiovascular and have been categorised into manageable sections; Screening, Casefinding and Management.
Screening
These reports identify patients not currently on the Hypertension register, whose last blood pressure was high. Different blood pressure (BP) thresholds are set to enable the prioritisation of assessment.
These reports are in the folder CDRC Quality > Cardiovascular
- ? Hypertension/BP 1.1 Screening Priority 1 – Consider repeat BP Last BP >=170/105 #
- ? Hypertension/BP 1.2 Screening Priority 2 – Consider repeat BP Last BP >=160/100 #
- ? Hypertension/BP 1.3 Screening Priority 3 – Consider repeat BP Last BP >=150/90 #
- ? Hypertension/BP 1.4 Screening Priority 4 – Consider repeat BP Last BP >=140/90 #
- ? Hypertension/BP 1.5 Screening – Other Groups 1.1 BAME – Consider repeat BP Last BP >=140/90
- ? Hypertension/BP 1.5 Screening – Other Groups 1.2 Core20Plus5 – Consider repeat BP Last BP >=140/90
- ? Hypertension/BP 1.5 Screening – Other Groups 1.3 Hard to reach – Consider repeat BP Last BP >=140/90
- ? Hypertension/BP 1.5 Screening – Other Groups 1.4 Hardest to reach – Consider repeat BP Last BP >=140/90
If your unit has opted into the optional Hypertension Resources or Cardiovascular Resources (see ‘Hypertension Opt-in Resources’ below), these patients will be flagged with the raised BP icon.
![Potential Hypertension
Last was >140/90 - consider repeat](https://cdrc.nhs.uk/wp-content/uploads/2022/10/image-37.png)
Consider inviting these patients for a follow up blood pressure or home blood pressure testing. Patients can be invited systematically using the searches or opportunistically using the patient status alert flag.
It might also be possible to direct them to local pharmacies taking part in the hypertension finding scheme.
Casefinding
The following reports will help identify patients that may not have been appropriately coded.
Report Name | Returns | Action |
? Hypertension/BP 2.1 Casefinding – Potential Hypertension indicator but no HT code | Patients with a code to suggest hypertension (e.g. hypertension annual review) without a QoF hypertension code | The QoF and Contracting template will help to identify the codes (see example below) |
? Hypertension/BP 2.2 Casefinding – Medication that might be for HT but no HT | Patients taking medication which might be for hypertension who don’t have an obvious indication for this. | |
? Hypertension/BP 2.3 Casefinding – ABPM>=135/85 and not appropriately coded | Patients with a home BP average reading >=135/85 (which defines hypertension) without a subsequent hypertension code. | |
? Drug to Diagnosis 004 – Betablocker without obvious indication | Also likely to detect other diagnoses such as hypertension, heart failure, SVT, CHD | |
? Drug to Diagnosis 005 – Calcium channel blocker without obvious indication | Also likely to detect other diagnoses such as hypertension, Raynauds, SVT, CHD | |
? Drug to Diagnosis 007 – RAS Drug without obvious indication | Also likely to detect other diagnoses such as CHD, diabetic kidney disease, heart failure, LVSD | |
? Drug to Diagnosis 009 – Thiazides without obvious indication |
Management
The following reports will help target patients for intervention. They have been arranged in such a way to facilitate prioritisation.
![](https://cdrc.nhs.uk/wp-content/uploads/2023/04/image.png)
Report Name | Returns | Intervention | Notes |
? Hypertension/BP 3.1 Management Priority 1 – Highest potential for intervention | Priority 1 patients. Has all three of: – 3 months overdue BP check. – Suspected poor concordance. – BP is >20/10 over NICE or personal target. | Review patient | |
? Hypertension/BP 3.2 Management Priority 2 – High potential for intervention | Priority 2 patients. Has two out of three of: – 3 months overdue BP check. – Suspected poor concordance. – BP is >20/10 over NICE or personal target. | Review patient | Patients with stage 1 hypertension without end organ damage who are off treatment are not included. Patients are not included if the last blood pressure was recorded in the last 6w allowing time for recent intervention to have an effect |
? Hypertension/BP 3.31 Management Priority 3a – Consider treatment intensification | Priority 3a Last BP is >30/15 above NICE or personal target. | Review patient and consider treatment intensification | Patients in priority 1 and 2 are excluded. |
? Hypertension/BP 3.32 Management Priority 3b – Consider Poor Concordance | Priority 3b Patients who need BP control who do not appear to be collecting antihypertensives | Consider review of concordance | Patients in priority 1 and 2 are excluded. |
? Hypertension/BP 3.33 Management Priority 3c – No BP check for 18m | Priority 3c Patients who need a BP check who are at least 6 months overdue | Consider inviting for review or requesting home BP | Patients in priority 1 and 2 are excluded. This includes patients with AAA, CHD, CKD, diabetes, hypertension, heart failure, PAD, stroke/TIA. |
? Hypertension/BP 3.41 Management Priority 4a – Consider treatment intensification | Priority 4a Last BP is >20/10 above NICE or personal target | Review patient and consider treatment intensification | Patients in priority 1 and 2 are excluded. |
? Hypertension/BP 3.43 Management Priority 4c – No BP check for 15m | Priority 4c Patients who need a BP check who are at least 3 months overdue a check | Consider inviting for review or requesting home BP | Patients in priority 1 and 2 are excluded. This includes patients with AAA, CHD, CKD, diabetes, hypertension, heart failure, PAD, stroke/TIA. |
? Hypertension/BP 3.5 Management Priority 5 – Consider treatment intensification | Priority 5 Last BP is above NICE or personal target | Review patient and consider treatment intensification | Patients in priority 1 and 2 are excluded. |
? Hypertension/BP 3.6 Management Priority 6 – Consider setting personal target | Priority 6 Patients who need BP control who don’t have a personal target | Consider setting a BP target | Includes: – Hypertension (unless stage 1 without end organ damage – Type 1 diabetes – Diabetes with micro/albuminuria – CKD |
Performance Reports
The following reports allow units to assess their performance with respect to blood pressure management. These searches cover people with any condition for which BP control is recommended – CKD, Diabetes, Hypertension and Stroke/TIA
![](https://cdrc.nhs.uk/wp-content/uploads/2022/10/image-51.png)
Templates
BP Detailed Blood Pressure
How to Access
In the lower left hand corner use the search bar, type in ‘BP Detailed Blood Pressure’ and select the following template:
![](https://cdrc.nhs.uk/wp-content/uploads/2023/06/image-7.png)
Alternatively, press F12 and search for ‘BP Detailed Blood Pressure’, this will return the aforementioned template.
Blood pressure can be recorded on the Core Data Entry template or more detailed blood pressure information can be seen/recorded on the BP Detailed Blood Pressure template which be reached from the Core Data Entry template or added to existing toolbars or templates.
![](https://cdrc.nhs.uk/wp-content/uploads/2022/10/image-1.gif)
The BP Detailed Blood Pressure template has the following features
Column 1 | Column 2 | Column 3 |
Space to record specific requirements for BP recording e.g. cuff size, which are to use/avoid | Most recent blood pressure monitoring comments | |
Link to BP Targets setting template | Current estimated NICE BP target Current QoF target Current patient specific target (if this has been set) | Indicator to describe current QoF performance regarding blood pressure (all QoF domains) |
Link to BP Exceptions template | ||
Space to record various clinic BPs | Most recent BP readings (all types) | Link to BP Graph which shows more detailed information about previous BP reading in data or graphical form |
Relevant home blood pressure codes Link to a printable home BP record sheet Link to the Communication Annexe to send SMS or email links for a BP recording sheet. Link to an average calculator Space to record home or ambulatory BP | Relevant information about previous home and ambulatory BP readings and codes |
The Guidance page has information about recording blood pressure and diagnosing hypertension
![](https://cdrc.nhs.uk/wp-content/uploads/2022/10/image.gif)
The Resources page has links to professional resources and a button to link to patient resources
![](https://cdrc.nhs.uk/wp-content/uploads/2022/10/image-2.gif)
Blood Pressure Target Setting
How to Access
In the lower left hand corner use the search bar, type in ‘BP Targets’ and select the following template:
![](https://cdrc.nhs.uk/wp-content/uploads/2023/06/image-4.png)
Alternatively, press F12 and search for ‘BP Targets’, this will return the aforementioned template.
The BP Target template shows estimated targets (NICE and QoF as these are not always aligned) and allows recording of patient specific targets. If a target is set which is not the default, it is helpful to record this as free text with the target – this free text will be displayed in the panel on the right.
![NICE Targets Targets Resources
BP Targets (NICE)
Estimated NICE Target <140
QoF Target
Target systolic ap
Target diastolic ap
Clinic BP
Estimated NICE Target
QoF Target
17 Jan 2022
17 Jan 2022
CKD and ACR
OR
TIDM AND 2 features ot
metabolic syndrome
OR
TIDM AND albuminuria
Type 1 diabetes
CKD
OR
Hypertension under 80y
Hypertension 80y +
< 130/80
< 135/85
< 140/90
< 150/90
ABPM or
HBPM
< 135/85
< 145/85
Target
Systolic
120-129 in
CKD
120-139 in
CKD
A QoF Achieved
Target systolic blood pressure
Target diastolic blood pressure
NO clear record of code for CKD
No record of diabetes
Show Renal Va Iues
NICE Hypertension
< 140 mm Hg
< go mm Hg
RCP stroke](https://cdrc.nhs.uk/wp-content/uploads/2022/10/image-42.png)
Blood Pressure Treatment
How to Access
In the lower left hand corner use the search bar, type in ‘BP Treatment CDRC’ and select the following template:
![](https://cdrc.nhs.uk/wp-content/uploads/2023/06/image-5.png)
Alternatively, press F12 and search for ‘BP Treatment’, this will return the aforementioned template.
The BP Treatment template provides guidance about how to treat blood pressure. The home page sets out BP targets, current treatment and the NICE pathway.
![BP When to Treat AF
BP Treatment
Targets
CHO
CKD Diabetes Gout Heart Failure
Estimated NICE Target <140
OOF Target
Target systolic bloom < 140
Indapamide 25mg tablets
Losanan 100mg tablets
=55y (not diabetic)
17Jan2022
Estimated NICE Target
OOF Target
Target diastolic bloomsgo 17 Jan 2022
NICE Hypertension Pathway
Diabetes OR
<55y not African/Caribbean
step 1 ACEI/A2R8
step2 AC
I/A2R8 + cca or TLD
step 3
African/Caribbean (not diabetic)
cca if ccanot tolerated)
cca + ACEi/A2R8* or TLD
27 Jun 2022take 28 tabl...
Antihypertensive Scripts * aps
27 Jun 2022take 28
Medication Timeline
Relevant Conditions
hite British - ethnic category 2001 censusß
21 Nov2017 W
No record of AF
NO clear record of CHO
NO clear record of code for CKD
No record of diabetes
ACEi/A2R8 + cca + thiazjde-like diuretic
Step 4 Consider low dose spironolactone (25mg) if K«4S
If spironolactone not tolerated, ineffective or
contraindicated, consider alpha or beta blocker
Thiazide-like diureticslndapamide - 2Smg (or 1 snig MR) cd - DO NOT INCREASE DOSE
Chlortalidone - intialty 12Smg-2Smg od- can be increased to SOmg
NS a dose of 12Smg chlortalidone requires quartering of a tablet
•ACEA2RBs
Consider A2RB instead of ACEi n Africans/Cariböeans
Different pathways may be recommended in the conditions below.
Diabetes
CHO
Gout
CKD
Heal Failure](https://cdrc.nhs.uk/wp-content/uploads/2022/10/image-45.png)
The When to Treat Page, provides guidance on when to start treatment.
![ap When to Treat AF CHO CKD Diabetes Gout Heart Failure
When to Start Treatment for Hypertension
NICE
stage 1 Hypertension (El 40/90 or ABPM/HBPM 35/85)
Start treatment if:
Under 80 AND at least one of
• Target organ damage
• Established cardiovascular disease
• Diabetes
• Renal disease
• loy CVD risk
• If under 60, consider Rx if
(QRISK underestimates lifetime risk in ßunger people)
stage 2 Hypertension (El 60/100 ABPWHBPM El 50/95)
Offer treatment to all
18 Feb2022
18 Fe02022
15Mar2022
15Mar2022
23 May 2022
23 May 2022
O/E - Diastolic BP reading
ONE - Systolic BP reading
O/E- Diastolic BP reading
O/E- Systolic BP reading
O/E- Diastolic BP reading
O/E- Systolic BP reading
NO clear record of CHO
NO clear record of code for CKD
No record of diabetes
No record of peripheral arterial disease
No record of stroke'TlA
Target Organ Damage
unne albumin/creatinine ratio
Urinary Blood
05 Nov 2008 Unne blood test = negative
02 Apr 2014 Urine blood test = negative
05 Feb 2017 unne blood test
Cardiovascular Risk
QRlSK2 cardiovascular disease 10 year
06 mg/mmol
12.26%
87 mmHg
146 mmHg
84 mmHg
158 mmHg
64 mmHg
102 mmHg
07 Jul 2021
12 Mar 2022](https://cdrc.nhs.uk/wp-content/uploads/2022/10/image-47.png)
There is also Disease specific pages which hosts guidance.
![BP When to Treat AF CHO CKD Diabetes
Heart Failure and Hypertension
NICE
Gout
Heart Failure
For all patients with heart failure avoid verapamil, diltiazem and short acting CCBs
Patients with left ventricular systolic dysfunction should usually be offered a:
ACEi ( or A2RB if ACEi not tolerated )
AND
Beta - blocker licensed for heart failure
For patients with heart failure and preserved LV function no specific treatment is
Hypertension with CKD Information
GFR calculated abbreviated > go ml_.L
GFR calculated abbreviated„75
GFR calculated abbreviated > go mu
06 Jul 2021
31 Jan 2022
23 May 2022
23 May 2022
Serum creatinine level
Serum potassium level
66 umol/L
4 6 mmoI/L23 May 2022
unne protein/creatinine ratio No numer„
Urine albumin/creatinine ran 06 mgJnm„ 07 Jul 2021
ACEi/A2R8 Exceptions
recommended.
Target Doses
Drug
Enalapril
Lisinopril
Perindopril
Ramipril
Candesanan
Losanan
Valsanan
Bisoprolol
Carvedllol
Nebl%.olol
Starting Dose
25mg
25mg
2mg
125mg
4 mg
12 5mg
40mg Od
1 25mg od
3 125mg bd
125mg od
Target Dose
10-20mg bd
20-35mg od
4mg od
5mg bd or 10mg od
32mg od
150mg od
160mg Od
10mg od
25-50mg bd
10mg od
Notes
mg if symptomatic with
10mg
30-35mg if symptomatic
with 20mg
Divided doses
recommended
25 mg target if <85kg or
Severe H F
Licensed for over 70s](https://cdrc.nhs.uk/wp-content/uploads/2022/10/image-46.png)
Hypertension CDRC Template
How to Access
In the lower left hand corner use the search bar, type in ‘Hypertension CDRC’ and select the following template:
![](https://cdrc.nhs.uk/wp-content/uploads/2023/06/image-3.png)
Alternatively, press F12 and search for ‘Hypertension CDRC’, this will return the aforementioned template.
The Hypertension CDRC template facilitates the review of patients with hypertension.
![Hypertension InvestigationjReferral aoF Ruleset Exceptions Resources
Hypertension
BP Targets
BP Graph
BP Hypertension Register
End Organ Damage
Core Data
Patient Resources
BP Treatment
BP Exceptions
On max tol Rx
011 Lipids
Hypertension Review
NICE Hypertension Summarv NICE Hypertension Guidance
Estimated NICE Target <140
OOF Target
Target systolic bl < 140 17 Jan 2022
Estimated NICE Target
OOF Target
Target diastolicb 17 Jan 2022
14 Dec2021 0/E-SystoIi=
12 Jan 2022 Average home
31 Jan 2022 0/E
18 Feb2022 0'E-
Systolic
15 Mar 2022 0/E
- Systolic
23 May 2022 0/E
Has HYPERTENSION
165m
160
120m
146
158m
102m
14 Dec 2021
12 Jan 2022
31 Jan2022
18 Fe02022
15Mar2022
23 May 2022
O'E- Diastolic
Average home
O'E- Diastolic
O'E- Diastolic
O'E- Diastolic
O'E- Diastolic
3737 KgJm•
87
12 May 2022 Body mass index - observation
1 1 Nov 2020 Enjoys light exercise
Current smoker
Alcohol intake
Indapamide 25mg tablets
Losanan 100mg tablets
10 Unitsmeek
11 Nov2020
27 Jun 2022 take on
27 Jun 2022 take
28 tablet
28 tablet
1226%
28 tablet
A QoF Achieved
12 Mar 2022
QRlSK2 cardiovascular disease 10 year risk score
Atorwastatin 20mg tablets
02 Jun 2022 take
LIPID TARGET NOT ACHIEVED
31 Jan 2022 Hypertension annual review
Scripts aps
Medication Timeline
<Previous](https://cdrc.nhs.uk/wp-content/uploads/2022/10/image-39.png)
The Hypertension CDRC template features:
- Information about estimated and actual BP targets with a link to the BP Target Setting template to record/update BP targets. QoF achievement is shown (this covers achievement for all BP related QoF indicators not just the hypertension domain).
- Recent blood pressure readings (of any type) and a link to the BP graph function.
- A panel which shows if the patient is on the hypertension register and specifically shows if the patient has stage 1 hypertension without end organ damage. Information about end organ damage is shown here. There are links to templates to add/remove patients from the hypertension register and to view and record information about End Organ Damage.
- A panel showing key lifestyle factors which contribute to hypertension. There is a link to the Core Data template to record lifestyle factors and deliver interventions / referrals. There is a link to patient information to manage blood pressure
The BP treatment panel shows current antihypertensive medication and will show prompts when applicable such as:
- Consider setting BP target
- Consider intensification of treatment
- Consider ACEi/A2RB when this is specifically indicated e.g. diabetic kidney disease
- Consider drug concordance when patients are not collecting antihypertensives.
There is a link to the BP Treatment template which shows the NICE pathway for treating raised blood pressure. There is also a link to record hypertension exception codes. The Scripts and BPs button will show previous antihypertensives along with BP readings making it easier to review progress with current and previous treatment.
![CORC Treatment with
All Previous Antihypertensive Medication
Indapamide 25mg tablets
Propranolol 10mg tablets
Bisoprolol 25mg tablets
Lisinopril 10mg tablets
Lisinopril 25mg tablets
Losanan 100mg tablets
take one 3 times/day
3 issues
4 issues
8 issues
7 issues
2 issues
3 issues
60 mmHg
110 mmHg
120 mmHg
80 mmHg
120 mmHg
80 mmHg
120 mmHg
80 mmHg
110 mmHg
60 mmHg
78 mmHg
120 mmHg
og sep 2013
27 Jun 2022
30 Apr 2020
08 Apr 2022
07 Apr 2022
14 Jul 2021
27 Jun 2022
27 Mar 2006
27 Mar 2006
29 Aug 2006
2g Aug 2006
1 a oct 2006
16 oct 2006
27 Mar 2007
27 Mar 2007
15 Jul 2008
15 Ju12008
a Feb 2010
6 Feb 2010
O/E- Diastolic BP reading
O/E- Systolic BP reading
O/E- Systolic BP reading
ONE- Diastolic BP reading
O/E- Systolic BP reading
O/E- Diastolic BP reading
O/E- Systolic BP reading
ONE- Diastolic BP reading
O/E- Systolic BP reading
O/E- Diastolic BP reading
O/E- Diastolic BP reading
ONE - Systolic BP reading
Propranolol 10mg tablets](https://cdrc.nhs.uk/wp-content/uploads/2022/10/image-40.png)
![15 Mar2022 ONE - Diastolic reading
15 Mar2022 ONE-Systolic reading
Bisoprolol 25mg tablets
Lisinopril 10mg tablets
Lisinopril 10mg tablets
Lisinopril 10mg tablets
Lisinopril 10mg tablets
Bisoprolol 25mg tablets
Bisoprolol 25mg tablets
Bisoprolol 25mg tablets
Bisoprolol 25mg tablets
Bisoprolol 25mg tablets
Bisoprolol 25mg tablets
Indapamide 25mg tablets
Losartan 100mg tablets
23 May2022 ONE- Diastolic reading
23 May2022 0/E-systoIic8P reading
Indapamide 25mg tablets
Losartan 100mg tablets
Losanan 100mg tablets
Indapamide 25mg tablets
take one daily
take one daily
take one daily
take one daily
take one daily
take one daily
take one daily
take one daily
take one daily
take one daily
take one daily
take one each morning
take one daily
take one each morning
take one daily
take one daily
take one each morning
84 mmHg
158 mmHg
04 Apr 2022
07 Apr 2022 Q
02 Jun 2022
05 May 2022
07 Apr 2022
26 Aug 2022
2g Jul 2022
01 Jul 2022
03 Jun 2022
06 May 2022
08 Apr 2022
06 May 2022
06 May 2022
64 mmHg
102 mmHg
06 Jun 2022 Q
06 Jun 2022 Q
27 Jun 2022
27 Jun 2022](https://cdrc.nhs.uk/wp-content/uploads/2022/10/image-41.png)
There is a panel showing information and CVD risk and lipid lowering therapy with a link to the lipid template
There is space to record that the review has been completed along with any relevant comments. The most recent review (and any comments) are shown in the panel alongside.
Hypertension End Organ Damage
How to Access
In the lower left hand corner use the search bar, type in ‘Hypertension End Organ Damage’ and select the following template:
![](https://cdrc.nhs.uk/wp-content/uploads/2023/06/image-6.png)
Alternatively, press F12 and search for ‘Hypertension End Organ Damage’, this will return the aforementioned template.
The Hypertension End Organ Damage template shows relevant information.
Previous information about renal function/proteinuria/haematuria can be displayed by clicking the <Expand button
The last ECG can be viewed by right clicking on it and choosing View content.
![Hypertension End Organ Damage
Conditions suggesting end organ damage include:
CHO
Heal failure
Left ventricular hypertrophy
Stroke
Kidney Damage
Assess renal function
Assess renal protein loss
Urine blood
Eye Damage
Fundoscopy
ECG Changes
12 lead ECG
No record of AF
NO clear record of CHO
NO clear record of code for CKD
No record of heart failure
No record of peripheral arterial disease
No record of strokefflA
23 May 2022
23 May 2022
07 Jul 2021
07 Jul 2021
02 Apr 2014
5 Feb 2017
Serum creatinine level
GFR calculated abbreviated MDRD
Urine albumin/creatinine ratio
Urine albumin/creatinine ratio
Urine blood test = negative
Urine blood test
66 umol/L
> go mUminm
0.6 mgJmmol
<Expand
CDRC Fundoscopy (last) view has no data for patient
C]
16 Nov 2007
06 Jul 2021
06 Jul 2021
ECG normal
ECG to Leadgate Surgery
121eadECG](https://cdrc.nhs.uk/wp-content/uploads/2022/10/image-43.png)
![16Nov2007
16Nov2007
05 Nov2008
28 Mar 2011
28 Mar 2011
31 Jul 2012
31 Jul 2012
02 Apr 2014
17 Apr2014
17 Apr2014
17 Apr2014
05Fe02017
21 Nov2017
21 Nov2017
08 Apr 2020
08 Apr 2020
11 Nov2020
11 Nov2020
07 Jul 2021
07 Jul 2021
31 Jan2022
31 Jan2022
23 May 2022
23May2022
GFR calculated abbreviated MDRD
Serum creatinine level
GFR calculated abbreviated MDRD
Serum creatinine level
Urine blood test = negative
GFR calculated abbreviated MORO
Serum creatinine level
GFR calculated abbreviated MORO
Serum creatinine level
Urine blood test = negative
GFR calculated abbreviated MDRD
GFR calculated abbreviated MORO
Serum creatinine level
Urine blood
GFR calculated abbreviated MDRD
Serum creatinine level
GFR calculated abbreviated MDRD
Serum creatinine level
GFR calculated abbreviated MDRD
Serum creatinine level
GFR calculated abbreviated MDRD
Serum creatinine level
Urine albumin/creatinine ratio
Urine albumin/creatinine ratio
Serum creatinine level
GFR calculated abbreviated MORO
Serum creatinine level
GFR calculated abbreviated MORO
70 umol/L
70 umol/L
76 mumin/1 73m*2
74 umol/L
63 u mol/L
> go mumin/1.73m*2
61 umol/L
> go mumin/1.73m*2
65 umol/L
> go munmn/1.73m*2
64 umol/L
> go munmn/1.73m*2
62 umol/L
> go munmn/1.73m*2
61 umol/L
116 mg/mmol
79 umoI/L
75 mumin/1 73m*2
66 umol/L
> go mumin/1 73m*2](https://cdrc.nhs.uk/wp-content/uploads/2022/10/image-44.png)
Additional Resources
Hypertension and Blood Pressure Patient Information Leaflet
This Patient Information template has links to useful patient resources – both weblinks and some printable resources for use from face to face consultations.
![](https://cdrc.nhs.uk/wp-content/uploads/2022/10/image-3.gif)
There is a link to the Communication Annexe which makes it easy to send information electronically to patients. This also allows the patient to send completed BP sheets back to the practice.
Hypertension Opt-in Resources
For practices who have recently joined the DCS group on SystmOne, PSAs and Protocols will not be automatically active. You can choose the level of activation you would like; opt-in to all or resource specific CDRC resource PSAs and Protocols. Alternatively you can choose not to opt-in and only use the Reports and Templates.
If you would like to activate that following, or all, CDRC PSAs and Protocols, please email contact-cdrc@ahsn-nenc.org.uk
The following resources are available to support Hypertension, Blood Pressure management and QoF Performance:
Resource | Trigger | Action |
Raised BP PSA (icon) | Displays for patients not on the hypertension register with raised BP | Consider repeat BP or home BP |
BP Target Protocol | Will trigger if the patient’s estimated BP target changes e.g. at new hypertension diagnosis | Consider adding a BP target |
Supporting Blood Pressure at Home
The following resources are available to support Blood Pressure at home.
Reports
The following searches will help identify patients who might benefit from blood pressure measurements at home.
These reports are found in the folder CDRC Quality > Cardiovascular
![](https://cdrc.nhs.uk/wp-content/uploads/2022/10/image-3.jpeg)
Report 1.10 identifies patients who need BP management (hypertension, diabetes, CKD) who have not achieved the NICE target for their combination of risk factors, unless they have a target BP recorded that has been achieved. People with moderate or severe frailty, care home residents and palliative care stages B/C/D are excluded.
Report 1.11 identifies patients in 1.10 who have had a record (in the past 12 months) of home BP measurement, referral for home BP, home BP not indicated, home BP declined.
The other searches use the same criteria but identify patients at increasing levels of risk, based on factors such as last BP level, comorbidities, history of engagement, concordance.
Template
Use the BP Detailed Blood Pressure template, highlighted above, to record relevant information and values
![](https://cdrc.nhs.uk/wp-content/uploads/2022/10/image-4.gif)
Use the PIL Hypertension and Blood Pressure template below for providing patient information.